Magenta Therapeutics, Inc.MGTANASDAQ

Revenue (LTM)

$2M

-67.3% YoY

Net Income (LTM)

$-162M

-91.1% YoY

Free Cash Flow

$-129M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 24	Dec 25
Revenue	0	0	0	6	2↓67.3%
Gross Profit	0	0	0	0	0
Operating Income	-79	-75↑5.1%	-81↓8.3%	-102↓25.9%	-178↓74.7%
Net Income	-69	-66↑5.2%	-72↓9.9%	-85↓18.0%	-162↓91.1%
EBITDA	-79	-75↑5.1%	-79↓5.7%	-102↓29.0%	-178↓74.7%
EPS Diluted	-1.43	-1.12↑21.7%	-23.05↓1958.0%	-21.75↑5.6%	0.00

Metric	Dec 20	Dec 21	Dec 22	Dec 24	Dec 25
Cash & Equivalents	58	132↑126.4%	58↓56.2%	23↓60.4%	51↑124.1%
Total Current Assets	152	177↑16.8%	116↓34.7%	281↑143.0%	409↑45.8%
Total Assets	162	190↑17.5%	147↓22.8%	374↑155.0%	531↑42.0%
Total Current Liabilities	11	11↓5.0%	15↑33.9%	18↑26.8%	31↑66.6%
Total Liabilities	18	17↓2.5%	41↑135.7%	22↓47.1%	38↑74.3%
Total Equity	144	173↑20.0%	106↓38.6%	352↑232.7%	493↑40.0%
Total Debt	0	0	30	1↓95.0%	1↓7.0%
Net Debt	-58	-132↓126.4%	-28↑79.0%	-21↑23.0%	-50↓133.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 24	Dec 25
Operating Cash Flow	-64	-60↑7.0%	-67↓12.7%	-78↓16.5%	-129↓65.1%
Capital Expenditure	-0	-1↓216.0%	-0↑75.2%	-0↑66.6%	-0↓102.9%
Free Cash Flow	-64	-61↑5.6%	-67↓10.9%	-78↓16.1%	-129↓65.1%
Stock-Based Comp	10	10↑3.7%	7↓31.9%	13↑83.6%	23↑76.8%
Net Change in Cash	-7	73↑1162.3%	-74↓200.7%	-109↓47.7%	28↑125.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance